about
Immune Homeostasis in Epithelial Cells: Evidence and Role of Inflammasome Signaling ReviewedThiol redox chemistry: role of protein cysteine oxidation and altered redox homeostasis in allergic inflammation and asthmaSilica-induced NLRP3 inflammasome activation in vitro and in rat lungsDifferences in gene expression and cytokine production by crystalline vs. amorphous silica in human lung epithelial cellsDynamic redox control of NF-kappaB through glutaredoxin-regulated S-glutathionylation of inhibitory kappaB kinase betaIndications for distinct pathogenic mechanisms of asbestos and silica through gene expression profiling of the response of lung epithelial cellsActivation of the glutaredoxin-1 gene by nuclear factor κB enhances signalingCatalase overexpression fails to attenuate allergic airways disease in the mouse.Similar matrix alterations in alveolar and small airway walls of COPD patients.A comparative study of matrix remodeling in chronic models for COPD; mechanistic insights into the role of TNF-α.Altered cigarette smoke-induced lung inflammation due to ablation of Grx1Nitric oxide represses inhibitory kappaB kinase through S-nitrosylationReactive nitrogen species and cell signaling: implications for death or survival of lung epithelium.SOD inactivation in asthma: bad or no news?Efficacy of IFN-λ1 to protect human airway epithelial cells against human rhinovirus 1B infection.Cigarette smoke extract induces a phenotypic shift in epithelial cells; involvement of HIF1α in mesenchymal transition.Cigarette smoke targets glutaredoxin 1, increasing s-glutathionylation and epithelial cell death.Modulation of glutaredoxin-1 expression in a mouse model of allergic airway diseaseNitric oxide and redox signaling in allergic airway inflammation.Redox-sensitive kinases of the nuclear factor-kappaB signaling pathway.Redox amplification of apoptosis by caspase-dependent cleavage of glutaredoxin 1 and S-glutathionylation of Fas.Increased glutaredoxin-1 and decreased protein S-glutathionylation in sputum of asthmatics.Emerging mechanisms of glutathione-dependent chemistry in biology and diseaseEffect of chronic hypoxia on RAGE and its soluble forms in lungs and plasma of mice.Nuclear factor kappaB, airway epithelium, and asthma: avenues for redox control.Association of plasma sRAGE, but not esRAGE with lung function impairment in COPD.Systemic and local inflammation in asthma and chronic obstructive pulmonary disease: is there a connection?Regulation of apoptosis through cysteine oxidation: implications for fibrotic lung disease.Glutathione biochemistry in asthma.Involvement of c-Jun N-Terminal Kinase in TNF-α-Driven Remodeling.Alteration of canonical and non-canonical WNT-signaling by crystalline silica in human lung epithelial cells.Advanced glycation end products and their receptor in age-related, non-communicable chronic inflammatory diseases; Overview of clinical evidence and potential contributions to disease.Silica induces NLRP3 inflammasome activation in human lung epithelial cellsInterferon-β induces a long-lasting antiviral state in human respiratory epithelial cells.Cigarette smoke extract induced exosome release is mediated by depletion of exofacial thiols and can be inhibited by thiol-antioxidants.In situ detection of S-glutathionylated proteins following glutaredoxin-1 catalyzed cysteine derivatization.In situ detection and visualization of S-nitrosylated proteins following chemical derivatization: identification of Ran GTPase as a target for S-nitrosylation.Ablation of Glutaredoxin-1 Modulates House Dust Mite-Induced Allergic Airways Disease in Mice.Protocols for the detection of s-glutathionylated and s-nitrosylated proteins in situ.Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease.
P50
Q26781987-597D1558-FCC8-456F-9848-D2DD4E83CA71Q27006988-7A500D44-A292-4CAD-B0FB-8BBD2AAD56A7Q28382977-6C4C20AA-E238-45A8-AE0C-B0C61EC818BFQ28383808-B981B04A-FB32-437D-B07A-84A4EEBA923BQ28390372-58291FAF-D2B1-4C2E-A286-7ABFC00C35B4Q28392117-41C3BC08-1A3E-4E36-8D0A-F2AD93E8838DQ28392256-A51FD39C-75F3-4AC3-AC3D-24E8D218B1C0Q33695246-70EE7B51-F272-48B4-9138-D4F425ACE524Q33747452-CF413F11-E52B-438C-8339-87EED581095EQ34295275-8003EF36-E173-41DC-B1F1-99A061086AD5Q34314059-9E0A36C7-1A41-4390-A6C8-3E11DB596012Q34830350-6E36D74B-D41F-45D4-A7BD-B1DB399FE501Q35019705-99D09C94-0FEE-41B2-A16A-168E50DD97FCQ35083768-791B38C8-D4E4-4614-943A-F4A387738CAAQ35154006-5282838A-AA45-47E6-9604-5DC83E739581Q35347946-5E490DD2-6D34-4C92-8E61-07E58200BFDEQ35684883-C28FF24B-4390-4709-B67C-DF8B4339244BQ35855278-8F40D0E1-CA21-4E61-8CFE-6FD724868D69Q36009379-F0CFAFA4-1D3A-4955-BB90-BAFB2826FF53Q36598867-C700787B-7200-4D28-8B86-AF2116B209ACQ37124872-2A563548-6A4A-4066-AFA2-91C465B4A705Q37373767-C0ED4798-FF58-41CB-86B0-19548694DB50Q37379699-0877F518-E1DB-4695-B1B4-31B39D3C2860Q37404091-64FAA9A2-A00F-40F2-ABD6-9955E91385A3Q37455687-A1D44AB5-19E8-4DB9-9B94-08539ED4A05CQ37620204-04C512C8-F920-4091-8A87-708FD404AAE5Q37653451-C2CF9946-64AD-4962-BB38-920390897D1CQ37780586-1DC358E6-FC6B-44A1-B5C8-ECCCFF1DC098Q37833717-89974770-8AB4-4886-974E-F17ED7824D70Q38729626-DC631762-C848-48C3-BEDA-A213C3773194Q38776957-07194F05-B980-4DFA-82A1-845AB7DE999CQ38884751-D5F1F55F-3CEB-4996-9849-13E83804C4D5Q39196025-30DC6FCA-082F-47C7-A67A-F153F7CE5247Q39234775-C7F9A8A1-0880-4F2A-813D-B4F1CBC41A00Q40271566-37EDDFC8-C941-401A-8DF7-4B7755EB7E68Q40309074-5E84F3BE-2AB7-4CD1-B382-4F46367A105CQ40487573-5C5E94AF-9BCB-434B-8EB2-5C07028C325DQ41091073-31E9B58B-0FFC-484C-9F82-C4E503D3D957Q42754719-387F6AB3-9DFC-41B8-89EE-0042B03E01E8Q43779676-0013AFE8-0300-4A61-9972-502B9E93CDC3
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Niki L Reynaert
@ast
Niki L Reynaert
@en
Niki L Reynaert
@es
Niki L Reynaert
@nl
type
label
Niki L Reynaert
@ast
Niki L Reynaert
@en
Niki L Reynaert
@es
Niki L Reynaert
@nl
prefLabel
Niki L Reynaert
@ast
Niki L Reynaert
@en
Niki L Reynaert
@es
Niki L Reynaert
@nl
P106
P31
P496
0000-0002-8577-8094